Efficacy and safety of anti-interleukin 6 receptor monoclonal antibody (tocilizumab) in Colombian patients with Takayasu arteritis.
Purpose: The aim of this study was to describe the efficacy and safety of anti–interleukin 6 receptor antibody (tocilizumab [TCZ]) in patients with severe or refractory Takayasu arteritis (TA). Methods: We describe 8 Colombian patients with severe and/or refractory TA treated with TCZ during a perio...
- Autores:
-
Cañas Dávila, Carlos Alberto
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2014
- Institución:
- Universidad ICESI
- Repositorio:
- Repositorio ICESI
- Idioma:
- eng
- OAI Identifier:
- oai:repository.icesi.edu.co:10906/78520
- Acceso en línea:
- http://journals.lww.com/jclinrheum/Abstract/2014/04000/Efficacy_and_Safety_of_Anti_Interleukin_6_Receptor.2.aspx
http://hdl.handle.net/10906/78520
http://dx.doi.org/10.1097/RHU.0000000000000098
- Palabra clave:
- Arteritis de Takayasu
Tratamiento
Ciencias socio biomédicas
Biomedical sciences
Medicina
Interleukin-6
Reumatología
- Rights
- openAccess
- License
- https://creativecommons.org/licenses/by-nc-nd/4.0/